Targeting SLC1A5 and SLC3A2/SLC7A5 as a potential strategy to strengthen anti-tumor immunity in the tumor microenvironment
Cancer cells are metabolically vigorous and are superior in the uptake of nutrients and in the
release of the tumor microenvironment (TME)-specific metabolites. They create an acidic …
release of the tumor microenvironment (TME)-specific metabolites. They create an acidic …
Plasmodium Genomics and Genetics: New Insights into Malaria Pathogenesis, Drug Resistance, Epidemiology, and Evolution
Protozoan Plasmodium parasites are the causative agents of malaria, a deadly disease that
continues to afflict hundreds of millions of people every year. Infections with malaria …
continues to afflict hundreds of millions of people every year. Infections with malaria …
Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc
Y Lee, P Wiriyasermkul, C Jin, L Quan… - Nature structural & …, 2019 - nature.com
The L-type amino acid transporter 1 (LAT1 or SLC7A5) transports large neutral amino acids
across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a …
across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a …
The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1
YAP and TAZ are transcriptional co-activators and function as the major effectors of the
Hippo tumor suppressor pathway, which controls cell growth, tissue homeostasis, and organ …
Hippo tumor suppressor pathway, which controls cell growth, tissue homeostasis, and organ …
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
P Xia, A Dubrovska - Frontiers in Oncology, 2023 - frontiersin.org
The SLC3A2 gene encodes for a cell-surface transmembrane protein CD98hc (4F2).
CD98hc serves as a chaperone for LAT1 (SLC7A5), LAT2 (SLC7A8), y+ LAT1 (SLC7A7), y+ …
CD98hc serves as a chaperone for LAT1 (SLC7A5), LAT2 (SLC7A8), y+ LAT1 (SLC7A7), y+ …
Attacking the supply wagons to starve cancer cells to death
EM Selwan, BT Finicle, SM Kim, AL Edinger - FEBS letters, 2016 - Wiley Online Library
The constitutive anabolism of cancer cells not only supports proliferation but also addicts
tumor cells to a steady influx of exogenous nutrients. Limiting access to metabolic substrates …
tumor cells to a steady influx of exogenous nutrients. Limiting access to metabolic substrates …
Heteromeric solute carriers: function, structure, pathology and pharmacology
SJ Fairweather, N Shah, S Brӧer - Protein Reviews: Volume 21, 2021 - Springer
Solute carriers form one of three major superfamilies of membrane transporters in humans,
and include uniporters, exchangers and symporters. Following several decades of …
and include uniporters, exchangers and symporters. Following several decades of …
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Y Yang, A Bolomsky, T Oellerich, P Chen… - Nature …, 2022 - nature.com
Oncogenic RAS mutations are common in multiple myeloma (MM), an incurable malignancy
of plasma cells. However, the mechanisms of pathogenic RAS signaling in this disease …
of plasma cells. However, the mechanisms of pathogenic RAS signaling in this disease …
SLC3A2 N-glycosylation and Golgi remodeling regulate SLC7A amino acid exchangers and stress mitigation
C Zhang, M Shafaq-Zadah, J Pawling… - Journal of Biological …, 2023 - ASBMB
Proteostasis requires oxidative metabolism (ATP) and mitigation of the associated damage
by glutathione, in an increasingly dysfunctional relationship with aging. SLC3A2 (4F2hc …
by glutathione, in an increasingly dysfunctional relationship with aging. SLC3A2 (4F2hc …
The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation
Malaria infection induces complex and diverse immune responses. To elucidate the
mechanisms underlying host–parasite interaction, we performed a genetic screen during …
mechanisms underlying host–parasite interaction, we performed a genetic screen during …